As promoter hypermethylation is a frequent event in malignant diseases, leading to reduced tumour suppressor gene expression, we then studied regulation of BRCA1 expression by promoter hypermethylation in AML patients. This evidence concerns the gene BRCA1 and acute myeloid leukemia.